Arkolith/Insider Trading/TMBR/Form 4

TardiMed Sciences LLC

10% OwnerTimber Pharmaceuticals, Inc. (TMBR) · full profile →Form 4 · filed Aug 20, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$168K
Net Open-Market Flow
-$168K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 20, 2021Sell(S)50K$0.91$46K4.4M
Aug 19, 2021Sell(S)50K$0.95$48K4.5M
Aug 18, 2021Sell(S)75K$1.00$75K4.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-108259) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML